Guiding you carefully and confidently.
Life Sciences
Whether your team of researchers and innovators is developing a new drug or medical device, seeking FDA approval, devising an exit strategy, going public or staying private, Weaver’s diverse team of professionals possesses deep knowledge of the intellectual property landscape, regulatory requirements, reimbursement strategies and commercial aspects. With a profound depth and breadth of experience in the life sciences industry, our professionals can guide you carefully and confidently through any phase of your development process.
Connect with us Featured
Trending
Insights & Resources
Unravel life sciences industry complexities, and discover the differences between FDA special review designations like Fast Track, Priority Review and Breakthrough.
The credit is aimed at bolstering and incentivizing the emerging biotechnology sector to create jobs and invest in NYC and is available 1/1/23-1/1/26.
Change Healthcare was impacted by a cybersecurity incident that breached its information technology network.
In a business sale, due diligence is critical to mitigate the risk of unexpected tax issues for buyers and sellers. Find out key components of tax due diligence.
A summary of changes to R&E expenditure tax treatment in the proposed Tax Relief for American Families and Workers Act of 2024.
Administrative, physical, and technical safeguards are an essential element of HIPAA security and essential for protecting PHI and ePHI.
Meet the team